Topix Pharmaceuticals, Inc.

Active Amityville, NY

Topix Pharmaceuticals, Inc. Overview

Topix Pharmaceuticals, Inc. filed as a Domestic Business Corporation in the State of New York on Thursday, March 23, 1989 and is approximately thirty-seven years old, according to public records filed with New York Department of State.

Name
Burt Shaffer 8 ~ Background Report ~	President Chief Executive Officer Director CEO Treasurer Secretary
Brenda Wu 1 ~ Background Report ~	President Director CEO
Douglas H. Vandenberg ~ Background Report ~	CFO
Brian Murphy ~ Background Report ~	Treasurer
Jonathan Waggoner ~ Background Report ~	Director
Andre Moura 1 ~ Background Report ~	Vice President
Steven Pinsky ~ Background Report ~	Chief Financial Officer
Stanley Shaffer ~ Background Report ~	Secretary Vice President

Florida Department of State

Filing Type:	Foreign for Profit Corporation
Status:	Active
State:	Florida
State ID:	F03000000043
Date Filed:	Friday, January 3, 2003
Registered Agent	Hubco Registered Agent Services, Inc.

Texas Secretary of State

Filing Type:	Foreign For-Profit Corporation
Status:	Active In existence
State:	Texas
State ID:	800160541
Date Filed:	Wednesday, January 8, 2003
Registered Agent	Hubco Registered Agent Services, Inc.

California Secretary of State

Filing Type:	Statement & Designation By Foreign Corporation
Status:	Active
State:	California
Foreign State:	New York
State ID:	02491738
Date Filed:	Monday, January 6, 2003
Registered Agent	Paracorp Incorporated

Nevada Secretary of State

Filing Type:	Foreign Corporation
Status:	Inactive Withdrawn
State:	Nevada
Foreign State:	New York
State ID:	E0117922016-2
Date Filed:	Friday, March 11, 2016
Date Expired:	Wednesday, March 28, 2018

New York Department of State

Filing Type:	Domestic Business Corporation
Status:	Active
State:	New York
State ID:	1337418
Date Filed:	Thursday, March 23, 1989
DOS Process	Topix Pharmaceuticals Inc.
Source Record	NY DOS

Corporate Notes

Date	Type	Note
3/23/1989	Name History/Actual	Pharmagen, Inc.
1/25/1996	Name History/Actual	Topix Pharmaceuticals Inc.
1/8/2003	Application for Certificate of Authority
3/12/2003	Change of Registered Agent/Office
12/31/2004	Public Information Report (PIR)
12/31/2005	Public Information Report (PIR)
12/31/2006	Public Information Report (PIR)
12/31/2007	Public Information Report (PIR)
12/31/2008	Public Information Report (PIR)
10/14/2009	Change of Registered Agent/Office
12/31/2009	Public Information Report (PIR)
12/31/2010	Public Information Report (PIR)
12/31/2011	Public Information Report (PIR)
12/31/2012	Public Information Report (PIR)
12/31/2013	Public Information Report (PIR)
12/31/2014	Public Information Report (PIR)
3/11/2016	Foreign Qualification	Initial Stock Value: No Par Value Shares: 200 ----------------------------------------------------------------- Total Authorized Capital: $ 0.00
3/22/2016	Initial List
12/31/2016	Public Information Report (PIR)
2/2/2017	Annual List
12/31/2017	Public Information Report (PIR)
12/31/2017	Public Information Report (PIR)
12/31/2017	Public Information Report (PIR)
3/26/2018	Withdrawal
12/31/2018	Public Information Report (PIR)
4/25/2019	Commercial Registered Agent Resignation	5/2/19
10/18/2019	Change of Registered Agent/Office
12/31/2019	Public Information Report (PIR)
12/31/2019	Public Information Report (PIR)

Trademarks for Topix Pharmaceuticals, Inc.

	Defense Serial Number: 77194750 Drawing Code: 4000
	Fluoro/Gly Serial Number: 77194740 Drawing Code: 4000
	Perfect 10 Peel Serial Number: 86023844 Drawing Code: 5000
	Gly/Sal Serial Number: 76382815 Drawing Code: 3000
	Benzaderm Serial Number: 74346588 Drawing Code:
	Replenix Serial Number: 76382814 Drawing Code: 1000
	Guardix Serial Number: 76382813 Drawing Code: 1000
	Aquix Serial Number: 76382817 Drawing Code: 1000
	Emolix Serial Number: 76382818 Drawing Code: 1000
	Eurix Serial Number: 76382819 Drawing Code: 1000